Clinical Trial Update: Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Fuling Yunhua Granules and Dihuang Baoyuan Granules in drug-naive Type 2 diabetes patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dihuang Baoyuan Granules
• Fuling Yunhua Granules

Snippet

Sponsor: Beijing Supreme Life Pharmaceutical Technology Co., Ltd. | Conditions: Diabetes Mellitus, Type 2, Diabetes | Phase 2 | Status: RECRUITING